NSABP Members' Area   Password Protected - Access   Limited to NSABP Participating   Institutions Only NSABP Foundation, Inc. General NSABP Information   Financial Conflicts of      Interest Policy   Contact the NSABP   Employment Clinical Trials Information   Clinical Trials Overview   Protocol Chart   Never Say Lost Treatment Trials Information   Protocol B-51   Protocol B-52   Protocol B-53/S1207   Protocol B-55/BIG 6-13 Prevention Trials Information   Protocol P-1 - BCPT   Protocol P-2 - STAR To report problems, ask questions or make comments, please send e-mail to: Webmaster@nsabp.pitt.edu

NSABP Clinical Trials Overview Protocol B-23 A Clinical Trial Comparing Short, Intensive AC ± Tamoxifen with Conventional CMF ± Tamoxifen in Node-Negative Breast Cancer Patients with ER-Negative Tumors Specific Aims The specific aims of NSABP Protocol B-23 are: (1) To determine whether four cycles of AC are superior to six cycles of CMF; and (2) to determine whether tamoxifen added to AC or CMF is more efficacious than AC or CMF alone